BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7079 related articles for article (PubMed ID: 27491172)

  • 21. Pharmaceutical Regulatory Framework in Ethiopia: A Critical Evaluation of Its Legal Basis and Implementation.
    Suleman S; Woliyi A; Woldemichael K; Tushune K; Duchateau L; Degroote A; Vancauwenberghe R; Bracke N; De Spiegeleer B
    Ethiop J Health Sci; 2016 May; 26(3):259-76. PubMed ID: 27358547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New ways of insulin delivery.
    Heinemann L
    Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Historical sketch of modern pharmaceutical science and technology (Part 3). From the second half of the 19th century to World War II].
    Yamakawa K
    Yakushigaku Zasshi; 1995; 30(1):1-10. PubMed ID: 11613518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The insulin preparation - Diasulin - that annoyed August Krogh].
    Plum R
    Dan Medicinhist Arbog; 1999; ():187-202. PubMed ID: 11639162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcitonin intranasal--unigene: Salcatonin intranasal--unigene.
    Drugs R D; 2004; 5(2):90-3. PubMed ID: 15293868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical companies and their drugs on social media: a content analysis of drug information on popular social media sites.
    Tyrawski J; DeAndrea DC
    J Med Internet Res; 2015 Jun; 17(6):e130. PubMed ID: 26032738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives.
    Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between the academic community and the pharmaceutical industry: the legislative background and its effect on spending on medical research and development.
    Matthews JH
    Clin Invest Med; 1996 Dec; 19(6):470-8. PubMed ID: 8959357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rules to be adopted for publishing a scientific paper.
    Picardi N
    Ann Ital Chir; 2016; 87():1-3. PubMed ID: 28474609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The Korean Pharmaceutical Industry and the Expansion of the General Pharmaceuticals Market in the 1950-1960s].
    Sihn KH
    Uisahak; 2015 Dec; 24(3):749-81. PubMed ID: 26819439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [An international medical expert committee's participation in uncovering the truth on the liquidation of Polish officers found in mass graves at Katyn in the spring of 1943 and the biography of a Danish participant, Helge Tramsen (1910-1979)].
    Rosdahl N
    Dan Medicinhist Arbog; 2008; 36():133-54. PubMed ID: 19831295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma Vaccine--AVAX Technologies: DNP-VACC, M-Vax.
    BioDrugs; 2003; 17(1):69-72. PubMed ID: 12534322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lauritz Toft and DUMEX--the man, the idea and the way to its realization].
    Overø K
    Theriaca; 2009; (38):115-32. PubMed ID: 20027790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Restrictions on the conduct of advertising of medicinal products in Poland and their violations.
    Czerw A; Marek EM
    Acta Pol Pharm; 2013; 70(4):769-76. PubMed ID: 23923402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Legal features of the drug advertising.
    Pashkov VM; Olefir AA; Bytyak OY
    Wiad Lek; 2017; 70(1):133-138. PubMed ID: 28343208
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 354.